Senior Director, Clinical Science - Atherosclerosis

Merck & Co.; San Francisco (CA); On-site; USD 250,000 - 320,000; Full time

Job summary

Merck & Co. in San Francisco seeks a Senior Director, Clinical Science, Atherosclerosis to provide strategic leadership across multiple studies and assets, shaping disease area strategy. The role collaborates with cross-functional teams to guide development planning, ensure scientific standards, and drive innovation in data review and decision-making.

Candidates should have deep expertise in atherosclerosis, with 8+ years in clinical drug development and proven leadership in a matrix environment.

Qualifications

• Significant experience in Clinical Development, Clinical Science, or related field.
• Demonstrated leadership across multiple studies, programs, or assets.
• Deep therapeutic area expertise in atherosclerosis and clinically meaningful endpoints.

Responsibilities

• Provide strategic Clinical Science leadership across the disease area and multiple studies.
• Guide interpretation of clinical data to inform development strategy and program decisions.
• Standardize Scientific approaches and ensure data quality and regulatory compliance.
• Collaborate with cross-functional teams to align study planning and governance discussions.
• Lead and develop Clinical Scientists within a matrix environment.

Skills

Atherosclerosis

Clinical Development

Clinical Sciences

Data Quality

Regulatory Compliance

Trial Design

People Leadership

Matrix Leadership

Medical Monitoring

Education

PhD or PharmD

8+ years pharma/clinical development experience

Job description

Merck & Co. in San Francisco seeks a Senior Director, Clinical Science, Atherosclerosis to provide strategic leadership across multiple studies and assets, shaping disease area strategy. The role collaborates with cross-functional teams to guide development planning, ensure scientific standards, and drive innovation in data review and decision-making.

Candidates should have deep expertise in atherosclerosis, with 8+ years in clinical drug development and proven leadership in a matrix environment.